Laquinimod

Laquinimod Uses, Dosage, Side Effects, Food Interaction and all others data.

Laquinimod is an immunomodulator developed by Active Biotech and produced by Teva Pharmaceutical Industries. It is currently under development in phase III trials for treatment of multiple sclerosis as an oral therapy, like fingolimod. It has been shown to reduce disease activity on magnetic resonance imaging and to be well tolerated orally.

Table Of contents

• Laquinimod
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Laquinimod
Generic	Laquinimod
Laquinimod Other Names	Laquinimod
Type
Formula	C19H17ClN2O3
Weight	Average: 356.81 Monoisotopic: 356.0927701
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in multiple sclerosis.

Innovators Monograph

You find simplified version here Laquinimod